Genworth Financial (GNW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
Advanced strategic priorities in 2025, focusing on aging solutions, financial flexibility, and sustainable long-term growth.
Delivered strong shareholder value through $245 million in share repurchases and robust capital returns from Enact, with $407 million received from its 81% ownership stake.
Expanded CareScout’s Quality Network to over 1,000 locations and launched Care Assurance, a new long-term care insurance product.
Completed the acquisition of Seniorly, accelerating expansion into direct-to-consumer channels and senior living communities.
Maintained self-sustainability of legacy insurance businesses, with MYRAP delivering $34.5 billion in net present value since 2012.
Voting matters and shareholder proposals
Four proposals up for vote: election of ten directors, advisory vote on executive compensation, approval of the 2026 Associate Stock Purchase Plan, and ratification of KPMG LLP as auditor for 2026.
Board recommends voting FOR all proposals.
No shareholder proposals will be presented due to procedural non-compliance.
Board of directors and corporate governance
Board consists of ten members, nine of whom are independent; diverse in tenure, background, and skills.
Board committees: Audit, Compensation, Governance, Risk, and Technology—all fully independent.
Technology Committee established as a permanent standing committee in 2026.
Annual board and committee self-evaluations, robust director onboarding, and ongoing education.
Stock ownership requirements and anti-hedging/pledging policies for directors and executives.
Latest events from Genworth Financial
- Key votes include director elections, executive pay, stock plan, and auditor ratification.GNW
Proxy filing6 Apr 2026 - Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025